These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Influence of metabolic control of insulin-dependent diabetes on plasma nucleotide levels (cAMP, cGMP) during bicycle exercise. Kuzmits R; Schernthaner G Diabet Med; 1986; 3(5):441-4. PubMed ID: 3030620 [TBL] [Abstract][Full Text] [Related]
3. Plasma clearance rates and renal clearance of 3H-labeled cyclic AMP and 3H-labeled cyclic GMP in the dog. Blonde L; Wehmann RE; Steiner AL J Clin Invest; 1974 Jan; 53(1):163-72. PubMed ID: 4357610 [TBL] [Abstract][Full Text] [Related]
4. Urinary excretion of cyclic adenosine 3',5'-monophosphate and cyclic guanosine 3',5'-monophosphate in malignancy. Gennari C; Francini G; Galli M; Lore F J Clin Pathol; 1978 Aug; 31(8):735-41. PubMed ID: 211147 [TBL] [Abstract][Full Text] [Related]
5. Insulin stimulates nitric oxide synthesis in human platelets and, through nitric oxide, increases platelet concentrations of both guanosine-3', 5'-cyclic monophosphate and adenosine-3', 5'-cyclic monophosphate. Trovati M; Anfossi G; Massucco P; Mattiello L; Costamagna C; Piretto V; Mularoni E; Cavalot F; Bosia A; Ghigo D Diabetes; 1997 May; 46(5):742-9. PubMed ID: 9133539 [TBL] [Abstract][Full Text] [Related]
6. Hyperkalemia, hyperglycemia, and plasma levels of cyclic AMP and cyclic GMP induced by portal vein injection of cyclic nucleotides and their butyryl derivatives into dogs. Nakashima T; Morita N; Nakanishi Y; Inoki M; Kurogochi Y Can J Physiol Pharmacol; 1982 Dec; 60(12):1584-91. PubMed ID: 6299491 [TBL] [Abstract][Full Text] [Related]
7. The effect of insulin on adenosine 3':5'-monophosphate and guanosine 3':5'-monophosphate concentrations in human plasma. Siddle K; Davies CJ; Shetty KJ; Elkeles RS Clin Sci Mol Med; 1976 Jun; 50(6):487-91. PubMed ID: 179751 [TBL] [Abstract][Full Text] [Related]
8. Enzyme immunoassays for the estimation of adenosine 3',5' cyclic monophosphate and guanosine 3',5' cyclic monophosphate in biological fluids. Horton JK; Martin RC; Kalinka S; Cushing A; Kitcher JP; O'Sullivan MJ; Baxendale PM J Immunol Methods; 1992 Oct; 155(1):31-40. PubMed ID: 1328396 [TBL] [Abstract][Full Text] [Related]
9. Plasma atrial natriuretic peptide and cyclic nucleotide levels before and after a marathon. Lijnen P; Hespel P; M'Buyamba-Kabangu JR; Goris M; Lysens R; Vanden Eynde E; Fagard R; Amery A J Appl Physiol (1985); 1987 Sep; 63(3):1180-4. PubMed ID: 2820919 [TBL] [Abstract][Full Text] [Related]
10. [Plasma levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP) in patients with thyropathies]. Nedvídková J; Felt V Cas Lek Cesk; 1984 Jul; 123(27):835-7. PubMed ID: 6091888 [No Abstract] [Full Text] [Related]
11. Responses of plasma adenosine 3',5'-monophosphate, blood glucose and plasma insulin to glucagon in humans. Søvik O; Heiervang E; Aksnes L; Selvig S Scand J Clin Lab Invest; 1981 Nov; 41(7):669-74. PubMed ID: 6280266 [TBL] [Abstract][Full Text] [Related]
12. Theophylline enhances glucose recovery after hypoglycemia in healthy man and in type I diabetic patients. Hvidberg A; Rasmussen MH; Christensen NJ; Hilsted J Metabolism; 1994 Jun; 43(6):776-81. PubMed ID: 8201970 [TBL] [Abstract][Full Text] [Related]
13. Glucagonostatic actions and reduction of fasting hyperglycemia by exogenous glucagon-like peptide I(7-36) amide in type I diabetic patients. Creutzfeldt WO; Kleine N; Willms B; Orskov C; Holst JJ; Nauck MA Diabetes Care; 1996 Jun; 19(6):580-6. PubMed ID: 8725855 [TBL] [Abstract][Full Text] [Related]
14. Comparison of the suppressive effects of elevated plasma glucose and free fatty acid levels on glucagon secretion in normal and insulin-dependent diabetic subjects. Evidence for selective alpha-cell insensitivity to glucose in diabetes mellitus. Gerich JE; Langlois M; Noacco C; Lorenzi M; Karam JH; Korsham PH J Clin Invest; 1976 Aug; 58(2):320-5. PubMed ID: 783198 [TBL] [Abstract][Full Text] [Related]
15. Determination of cyclic guanosine- and cyclic adenosine monophosphate (cGMP and cAMP) in human plasma and animal tissues by solid phase extraction on silica and liquid chromatography-triple quadrupole mass spectrometry. Van Damme T; Zhang Y; Lynen F; Sandra P J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Nov; 909():14-21. PubMed ID: 23153638 [TBL] [Abstract][Full Text] [Related]
16. Increased plasma endothelin-1 and intraplatelet cyclic guanosine monophosphate in men with disturbed glucose metabolism. Anwaar I; Gottsäter A; Eriksson K; Jacobsson L; Lindgärde F; Mattiasson I Diabetes Res Clin Pract; 2000 Oct; 50(2):127-36. PubMed ID: 10960723 [TBL] [Abstract][Full Text] [Related]
17. Plasma cyclic nucleotide responses to insulin-induced hypoglycaemia and methacholine in patients with hyperthyroidism. Okada F; Ide H; Hata S; Honma M; Ui M Eur J Clin Invest; 1980 Feb; 10(1):81-6. PubMed ID: 6245892 [TBL] [Abstract][Full Text] [Related]
18. Platelet cAMP and cGMP in essential hypertension. Hoffmann G; Göbel BO; Harbrecht U; Vetter H; Düsing R Am J Hypertens; 1992 Nov; 5(11):847-50. PubMed ID: 1280952 [TBL] [Abstract][Full Text] [Related]
19. Urinary levels of cyclic guanosine monophosphate (cGMP) in patients with cancer of the uterine cervix: a valuable prognostic factor of clinical outcome? Orbo A; Jaeger R; Sager G Eur J Cancer; 1998 Aug; 34(9):1460-2. PubMed ID: 9849432 [TBL] [Abstract][Full Text] [Related]
20. Plasma cyclic nucleotide responses to psychological stress in normal and neurotic subjects. Okada F; Honma M; Ui M J Clin Endocrinol Metab; 1983 Jul; 57(1):78-81. PubMed ID: 6304137 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]